Evidence map›Paper›PMID 36364114›Full record

ArticleMolecules (Basel, Switzerland)2022

Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway.

Thangjam Davis Singh, Ningthoujam Indrajit Singh, Khuraijam Mrinalini Devi, Remmei Meiguilungpou, Lhaineichong Khongsai, Lisam Shanjukumar Singh, Naresh Chandra Bal, Ningombam Swapana, Chingakham Brajakishor Singh, Thiyam Ramsing Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thangjam Davis SinghDepartment of Biotechnology, Manipur University, Canchipur, Imphal 795003, Manipur, India.
Ningthoujam Indrajit SinghInstitute of Bioresources and Sustainable Development, Takyelpat, Imphal 795001, Manipur, India.ORCID 0000-0001-8860-325X
Khuraijam Mrinalini DeviDepartment of Biotechnology, Manipur University, Canchipur, Imphal 795003, Manipur, India.
Remmei MeiguilungpouDepartment of Biotechnology, Manipur University, Canchipur, Imphal 795003, Manipur, India.
Lhaineichong KhongsaiInstitute of Bioresources and Sustainable Development, Takyelpat, Imphal 795001, Manipur, India.
Lisam Shanjukumar SinghDepartment of Biotechnology, Manipur University, Canchipur, Imphal 795003, Manipur, India.
Naresh Chandra BalSchool of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar 751024, Odisha, India.ORCID 0000-0002-2859-6315
Ningombam SwapanaDepartment of Chemistry, Manipur Technical University, Imphal 795001, Manipur, India.ORCID 0000-0003-3957-0548
Chingakham Brajakishor SinghInstitute of Bioresources and Sustainable Development, Takyelpat, Imphal 795001, Manipur, India.
Thiyam Ramsing SinghDepartment of Molecular Biology and Biotechnology, Tezpur University, Napaam, Tezpur 784028, Assam, India.

Funding

Department of Biotechnology, Government of India BT/RLF/Reentry Reentry/23/2011
6 · The paper itself

Abstract

The use of cisplatin as a chemotherapeutic drug is impeded by the development of drug resistance. Combination therapies of a chemosensitizer for cisplatin have been studied, but with little success, and the search for an effective combination therapy is continuing. Our earlier reports have shown that

Indexed as

Fanconi AnemiaNeoplasmsApoptosisCell Line, TumorCell ProliferationCisplatinHumansCisplatinapoptosischemotherapycisplatinFANCD2Zanthoxylum

Identifiers

PMID36364114
PMCPMC9654912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.